~~<i id='1290847F13'><strike id='1290847F13'><tt id='1290847F13'><pre id='1290847F13'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：leisure time 2025-09-06 08:02:03 Page View：49985

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma
Next article： Psychedelics group wrestles with new pharma identity

focus

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Addiction doctors spar with methadone clinics over legislation

SamuelCorum/GettyImagesLawmakersonTuesdaywilldebateanaddictionmedicineproposalthatwouldhavebeenconsi

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Study: People of West African ancestry at greater risk of cardiac amyloidosis

AdobeAmongcardiologists,it’sknownthattransthyretincardiacamyloidosis,atypeofheartdisease,iscausedbyt

WSS

leisure time

leisure time

knowledge

focus

Study: People of West African ancestry at greater risk of cardiac amyloidosis